Founded Year

2019

Stage

Unattributed | Alive

Total Raised

$210.77M

Last Raised

$23M | 10 mos ago

About Cambrian Bio

Cambrian Bio operates as a clinical-stage drug development company that focuses on the biomedicine sector. The company's main offerings include the development of therapeutics designed to prevent diseases and lengthen healthspan. Cambrian Bio primarily serves the healthcare industry. It was founded in 2019 and is based in New York, New York.

Headquarters Location

228 Park Avenue South Suite 66643

New York, New York, 10003,

United States

516-962-3186

Loading...

Cambrian Bio's Products & Differentiators

    therapeutics targeting a biological driver of aging

    https://www.cambrianbio.com/pipeline

Loading...

Research containing Cambrian Bio

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Cambrian Bio in 1 CB Insights research brief, most recently on Jan 10, 2024.

Expert Collections containing Cambrian Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cambrian Bio is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,309 items

Cambrian Bio Patents

Cambrian Bio has filed 1 patent.

The 3 most popular patent topics include:

  • computer security
  • internet privacy
  • smartwatches
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/19/2020

1/2/2024

Social networking services, Computer security, Internet privacy, Smartwatches, Virtual communities

Grant

Application Date

12/19/2020

Grant Date

1/2/2024

Title

Related Topics

Social networking services, Computer security, Internet privacy, Smartwatches, Virtual communities

Status

Grant

Latest Cambrian Bio News

Anti-Aging Drugs Market Forecast Report to 2040, with Profiles of AgelessRx, Betterhumans, BioAge Labs, bioXcellerator, Cambrian Biopharma, Rejuvenate Bio, UT Health San Antonio, and More - ResearchAndMarkets.com

Oct 29, 2025

and Sales Forecast of Drugs" report has been added to ResearchAndMarkets.com's offering. The anti-aging drugs market is estimated to grow from USD 79 million in the 2025, to USD 2.80 billion by 2040, representing a higher CAGR of 27% during the forecast period. Anti-Aging Therapeutics Market: Growth and Trends Researchers and innovators worldwide are focusing their efforts on the development of therapeutics that can extend life expectancy of an individual by targeting the pathophysiology of aging. Numerous start-ups and academic / research institutes globally are exploring a variety of anti-aging therapies at various stages of development. It is worth mentioning that anti-aging drug providing companies are using various methods, such as advancements in rigorous clinical trial services to expedite market approval procedure and incorporation of artificial intelligence to develop better anti-aging drugs. Additionally, technological advancements like organ-on-chip (promising alternative to conventional testing procedures) in the anti-aging domain has resulted in the development of targeted and effective longevity drugs. With the growing geriatric population, the ongoing R&D initiatives and the increasing funding investments, the anti-aging therapeutics market is expected to experience significant growth in the foreseen future. With the growing geriatric population, the ongoing R&D initiatives and the increasing funding investments, the anti-aging therapeutics market is expected to experience significant growth in the foreseen future. Anti-Aging Therapeutics Market: Key Insights The report delves into the current state of the anti-aging therapeutics market and identifies potential growth opportunities within industry. Some key findings from the report include: Presently, more than 65 anti-aging therapeutics are being developed worldwide; majority of the developers are small firms based in North America. These therapeutics, ranging from a variety of biologics and small molecules, are currently being investigated across different phases of development. More than 55% of partnership agreements were inked in the past two years. ~USD 4 billion has been invested by both private and public investors, since 2018 Over 660 patents related to anti-aging therapeutics have recently been filed / granted, indicating the growing intellectual capital in this domain. 230+ articles related to anti-aging therapeutics have been published over the last four years. The market is expected to grow at an annualized rate of over 15%; the overall opportunity is anticipated to be well distributed across different types of molecules, types of aging and key geographical regions. Europe and Asia Pacific are anticipated to capture more than 75% of the market share, by 2040. Anti-Aging Therapeutics Market: Research Coverage Market Sizing and Opportunity Analysis : The report features a thorough analysis of the global anti-aging therapeutics market, in terms of the key market segments, namely type of molecule, type of aging, geographical regions and sales forecast of drugs. Market Landscape: An in-depth assessment of the companies involved in anti-aging therapeutics market, based on several relevant parameters, such as year of establishment, company size, location of headquarters, phase of development, type of aging, type of molecule, mechanism of action, type of developer. Company Competitiveness Analysis : A comprehensive competitive analysis of anti-aging therapeutics market, examining factors, such as developer strength and portfolio strength and portfolio diversity. Company Profiles : Detailed profiles of key developers engaged in the anti-aging therapeutics market, focused on overview of the company, financial information (if available), drug portfolio, and recent developments and an informed future outlook. Patent Analysis : An insightful analysis of the various patents filed / granted in anti-aging therapeutics market, based on various parameters, such as type of patent, patent publication year, geography, CPC Symbols, type of applicant, emerging focus area, patent age, patent benchmarking, patent characteristics, and patent valuation. Publication Analysis : An insightful analysis of the overall publications reported in this domain, based on various parameters, such as year of publication, type of publication and geography. Key Questions Answered in this Report How many companies are currently engaged in this market? Which are the leading companies in this market? What factors are likely to influence the evolution of this market? What is the current and future market size? What is the CAGR of this market? How is the current and future market opportunity likely to be distributed across key market segments? Key Players in the Anti-aging Therapeutics Market Profiled in the Report Include AgelessRx ANOVA Institute of Regenerative Medicine Betterhumans BioAge Labs bioXcellerator Cambrian Biopharma Gero.ai, Mayo Clinic Rejuvenate Bio UT Health San Antonio Reasons to Buy this Report The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants. Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies. The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects. Additional Benefits Complimentary Excel Data Packs for all Analytical Modules in the Report 15% Free Content Customization Detailed Report Walkthrough Session with Research Team Report Segmentation Type of Molecule Biologics Small Molecules Type of Aging Cellular Aging Immune Aging Metabolic Aging Others Geographical Regions North America Europe Asia Pacific Rest of the World For more information about this report visit https://www.researchandmarkets.com/r/l1x5iz About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on businesswire.com: https://www.businesswire.com/news/home/20251029381603/en/ Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Cambrian Bio Frequently Asked Questions (FAQ)

  • When was Cambrian Bio founded?

    Cambrian Bio was founded in 2019.

  • Where is Cambrian Bio's headquarters?

    Cambrian Bio's headquarters is located at 228 Park Avenue South, New York.

  • What is Cambrian Bio's latest funding round?

    Cambrian Bio's latest funding round is Unattributed.

  • How much did Cambrian Bio raise?

    Cambrian Bio raised a total of $210.77M.

  • Who are the investors of Cambrian Bio?

    Investors of Cambrian Bio include Future Ventures, Apeiron Investment Group, Moore Capital Management, Anthos Capital, SALT Fund and 16 more.

  • What products does Cambrian Bio offer?

    Cambrian Bio's products include therapeutics targeting a biological driver of aging.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.